AVDL Company Profile and Key Details
Avadel Pharmaceuticals plc
AVDL Stock Price Chart
Stock Price Today
Avadel Pharmaceuticals plc (AVDL) stock surged +1.94%, trading at $7.90 on NASDAQ, up from the previous close of $7.75. The stock opened at $7.88, fluctuating between $7.63 and $8.03 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland.
Company Information
| Employees | 154 |
| Beta | 1.63 |
| Sales or Revenue | $27.96M |
| 5Y Sales Change% | -0.874% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
Frequently Asked Questions
Avadel Pharmaceuticals plc (NASDAQ: AVDL) stock price is $7.90 in the last trading session. During the trading session, AVDL stock reached the peak price of $8.03 while $7.63 was the lowest point it dropped to. The percentage change in AVDL stock occurred in the recent session was 1.94% while the dollar amount for the price change in AVDL stock was $0.15.
The NASDAQ listed AVDL is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector. Avadel Pharmaceuticals plc designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Gregory J. Davis
Vice President of Corporation and Bus. Devel.
Mr. Gregory J. Divis Jr.
Chief Executive Officer & Director
Mr. Thomas S. McHugh
Senior Vice President & Chief Financial Officer
Mr. Jerad G. Seurer
Gen. Counsel & Company Sec.
Mr. Christian Kalita Pharm.D
Chief Pharmacist and Director of Quality Assurance & Regulatory Affairs
Dr. Douglas J. Williamson
Chief Medical Officer
Mr. Mark W. Elrod
Vice President of Sales
Ms. Angie Woods
Vice President of People & Culture
Dr. Jordan S. Dubow M.D.
Consultant
Dr. Jason M. Vaughn
Senior Vice President of Technical Operations
Ms. Jennifer Gudeman PharmD
Senior Vice President of Medical & Clinical Affairs
Mr. Steven G. Sullivan
Vice President of Sales & Marketing and Head of Commercial Operations
Mr. Richard J. Kim
Chief Commercial Officer
AVDL's closing price is 6.9% higher than its 52-week low of $7.39 where as its distance from 52-week high of $19.09 is -58.62%.
Number of AVDL employees currently stands at 154.
Official Website of AVDL is: https://www.avadel.com
AVDL could be contacted at phone 353 190 15201 and can also be accessed through its website. AVDL operates from 10 Earlsfort Terrace, Dublin, 2, Ireland.
AVDL stock volume for the day was 1.68M shares. The average number of AVDL shares traded daily for last 3 months was 1.46M.
The market value of AVDL currently stands at $761.26M with its latest stock price at $7.90 and 96.36M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com